Evidence map›Paper›PMID 23770333›Full record

ArticleVaccine2013

Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter: an efficacious orally-administered mucosal vaccine against salmonellosis in pigs.

Matteo Gradassi, Michele Pesciaroli, Nicola Martinelli, Jessica Ruggeri, Paola Petrucci, Walid Hamdy Hassan, Manuela Raffatellu, Frine Eleonora Scaglione, Serena Ammendola, Andrea Battistoni and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Vaccine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Microorganisms · 2021
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Competition for zinc binding in the host-pathogen interaction.Frontiers in cellular and infection microbiology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Matteo GradassiIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy.
Michele Pesciaroli
Nicola Martinelli
Jessica Ruggeri
Paola Petrucci
Walid Hamdy Hassan
Manuela Raffatellu
Frine Eleonora Scaglione
Serena Ammendola
Andrea Battistoni
Giovanni L Alborali
Paolo Pasquali
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini" · ITIstituto Superiore di Sanità · ITUniversity of Rome Tor Vergata · ITBeni-Suef University · EGUniversity of California, Irvine · USUniversity of Turin · IT

Funding

Mucosal barrier function during Salmonella infectionR01AI083663 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI RAFFATELLU, MANUELA · 2010 to 2014
$1.9M
NIAID NIH HHS AI083663NIAID NIH HHS R01 AI083663
6 · The paper itself

Abstract

We have recently demonstrated that an attenuated strain of Salmonella enterica serovar Typhimurium unable to synthesize the zinc transporter ZnuABC (S. Typhimurium ΔznuABC), is able to protect mice against systemic and enteric salmonellosis and is safe in pigs. Here, we have tested the protective effects of S. Typhimurium ΔznuABC in pigs. Resistance to challenge with the fully virulent strain S. Typhimurium ATCC 14028 was assessed in animals vaccinated with S. Typhimurium ΔznuABC (two dosages tested), in controls vaccinated with a formalin-inactivated virulent strain and in unvaccinated controls. Clinical signs of salmonellosis, faecal shedding and bacterial colonization of organs were used to assess vaccine-induced protection. After the challenge, pigs vaccinated with the attenuated S. Typhimurium ΔznuABC strain did not display clinical signs of salmonellosis (fever or diarrhoea). The vaccine also reduced intestinal tract colonization and faecal shedding of the fully virulent Salmonella strain, as compared to control groups. S. Typhimurium ΔznuABC represents a promising candidate vaccine against salmonellosis in pigs.

Indexed as

Administration, OralAnimalsBacterial ProteinsBacterial SheddingCation Transport ProteinsFecesFemaleImmunity, MucosalInterferon-gammaMouth MucosaSalmonella Infections, AnimalSalmonella typhimuriumSalmonella VaccinesSus scrofaTumor Necrosis Factor-alphaVaccines, AttenuatedBacterial ProteinsCation Transport ProteinsInterferon-gammaSalmonella VaccinesTumor Necrosis Factor-alphaVaccines, AttenuatedMucosal vaccineOral deliveryPigsSalmonellaSalmonellosisS. Typhimurium ΔznuABCVaccine

Identifiers

PMID23770333
PMCPMC3880306
OpenAlexW2109991843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.